Quarterly share demat compliance certificate filed with BSE

Compliance View source PDF Explain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

-1.1%Reaction day

₹575.00

prior close

—

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.8%-1.9% vs market

Pharmaceuticals peers, median of 167sector-0.1%-0.9% vs sector

On the reaction day the stock moved 1.9 pts less than Nifty Microcap 250 and 0.9 pts less than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

—

10m

—

15m

—

30m

—

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

-1.1+0.8-1.9-0.1-0.9

Next day

-5.3+1.0-6.3-0.1-5.2

-1.4+1.7-3.2-0.2-1.2

-2.3+0.1-2.4-0.9-1.4

-5.0+0.8-5.8-0.7-4.3

-7.5-0.9-6.6-2.2-5.3

-12.9-4.5-8.4-4.4-8.4

15d

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 167Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Coral Laboratories has filed a routine SEBI compliance certificate with BSE for the quarter ended 30 September 2026. The certificate from its registrar MUFG Intime India (formerly Link Intime) confirms that share certificates received for dematerialization during the quarter were properly verified, listed on the stock exchanges, and that cancelled paper certificates were replaced with the depository as the registered owner within the prescribed timelines. Signed by Director and CFO Sushma Kadkade.

Likely market impact

Routine quarterly regulatory filing with no material impact on shareholders or the stock price.